MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS
S. Daneshmand, Renata Zaucha, N. Vasdev, B. Gartrell, Y. Lotan, S.A. Hussain, Eugene K Lee, G. Procopio, F. Galanternik, Géraldine Pignot, D. Sundi, H.J. Cutuli, L. Crow, V. Naini, Spyros Triantos, M. Baig, J. Maranchie
{"title":"MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS","authors":"S. Daneshmand, Renata Zaucha, N. Vasdev, B. Gartrell, Y. Lotan, S.A. Hussain, Eugene K Lee, G. Procopio, F. Galanternik, Géraldine Pignot, D. Sundi, H.J. Cutuli, L. Crow, V. Naini, Spyros Triantos, M. Baig, J. Maranchie","doi":"10.1016/j.urolonc.2024.01.172","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"432 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
